StockNews.com Begins Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC)
StockNews.com began coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research note published on Wednesday. The brokerage issued a hold rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Price Performance Shares of CYCC opened at $2.28 on Wednesday. The business has a 50-day moving average of $2.31 and a 200 day […]
More Stories
Insider Selling: Yum! Brands, Inc. (NYSE:YUM) CEO Sells $969,991.22 in Stock
Yum! Brands, Inc. (NYSE:YUM – Get Free Report) CEO David W. Gibbs sold 7,073 shares of the firm’s stock in...
Home Bancshares, Inc. (Conway, AR) (NYSE:HOMB) Holdings Decreased by Truist Financial Corp
Truist Financial Corp lessened its stake in Home Bancshares, Inc. (Conway, AR) (NYSE:HOMB – Free Report) by 11.0% during the...
Truist Financial Corp Trims Stake in Mobileye Global Inc. (NASDAQ:MBLY)
Truist Financial Corp lessened its stake in shares of Mobileye Global Inc. (NASDAQ:MBLY – Free Report) by 40.9% during the...
SkyWest, Inc. (NASDAQ:SKYW) Shares Sold by Truist Financial Corp
Truist Financial Corp lessened its stake in SkyWest, Inc. (NASDAQ:SKYW – Free Report) by 2.8% in the 4th quarter, according...
Innovator U.S. Small Cap Power Buffer ETF – July (BATS:KJUL) Holdings Lifted by Truist Financial Corp
Truist Financial Corp raised its stake in Innovator U.S. Small Cap Power Buffer ETF – July (BATS:KJUL – Free Report)...
Truist Financial Corp Reduces Stock Holdings in Americold Realty Trust, Inc. (NYSE:COLD)
Truist Financial Corp lowered its holdings in Americold Realty Trust, Inc. (NYSE:COLD – Free Report) by 46.2% during the fourth...